The objective of this study was to investigate the relationship between increased prevalence of cardiovascular disease and glucose regulation status in Chinese patients with metabolic syndrome (MetS). All patients underwent an oral glucose tolerance test (2-h post-load plasma glucose) to determine their glucose regulation status and had their brachial-ankle pulse wave velocity (baPWV) measured. Of the 590 patients included in the study, 115 (19.5%) had normal glucose tolerance, 114 (19.3%) had impaired fasting glucose (IFG) alone, 38 (6.4%) had impaired glucose tolerance (IGT) alone, 197 (33.4%) had diabetes mellitus and 126 (21.4%) had combined glucose intolerance (CGI; IFG plus IGT). Patients with diabetes mellitus had a significantly higher baPWV compared with all other groups and patients with CGI had a significantly higher baPWW compared with patients with IFG. Dysglycaemia was common in patients with MetS. An increased prevalence of cardiovascular disease in patients with MetS was related to their glucose regulation status.
Introduction
Metabolic syndrome (MetS), characterized by a clustering of abdominal obesity, hypertriglyceridaemia, reduced levels of high-density lipoprotein cholesterol (HDL-C), elevated blood pressure and high fasting blood glucose levels, has been associated with an increased risk of developing diabetes mellitus (DM) and cardiovascular disease, as well as an increased mortality from cardiovascular disease and all-cause death. 1, 2 Insulin resistance, a state of decreased biological response to physiological concentrations of insulin, is a key component of MetS. 3 With the onset of insulin resistance, normoglycaemia is achieved by increasing the secretion of insulin from pancreatic β-cells resulting in hyperinsulinaemia. This state of 'prediabetes' manifests clinically as impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT). Further resistance to insulin results in a failure to achieve normoglycaemia despite increased insulin *W Gong and Z Yang contributed equally to this work. W Gong, Z Yang, W Ye et al. Dysglycaemia and CV disease in metabolic syndrome secretion, resulting in DM. 4 DM is a wellestablished cardiovascular disease risk factor, which some authors consider to be a coronary heart disease risk equivalent. 2 Because of the controversy that has surrounded the concept of MetS, a thorough understanding of the association between the syndrome and DM -one of the main risks for people with MetS -is critical to furthering the debate on the scientific relevance of this syndrome. The present study was designed to investigate whether the association of MetS with an increased prevalence of cardiovascular disease is related to glucose regulation status in individuals with MetS.
Patients and methods

PATIENTS
In this observational study, patients with MetS were randomly recruited from the metabolic outpatient unit at HuaShan Hospital, Shanghai, China, between September 2007 and August 2008. The patients were diagnosed according to International Diabetes Federation (IDF) criteria, 5 i.e. ethnic-specific values for waist circumference (males ≥ 90 cm, females ≥ 80 cm) as a measure of central obesity, plus any two of the following: (i) raised triglyceride levels (≥ 1.7 mmol/l), or specific treatment for this lipid abnormality; (ii) reduced highdensity lipoprotein cholesterol (HDL-C) levels (males < 1.03 mmol/l, females < 1.29 mmol/l), or specific treatment for this lipid abnormality; (iii) raised blood pressure (systolic [SBP] ≥ 130 mmHg or diastolic [DBP] ≥ 85 mmHg), or treatment of previously diagnosed hypertension; (iv) raised plasma glucose (fasting plasma glucose [FPG] ≥ 5.6 mmol/l), or previously diagnosed type 2 diabetes. The study protocol was approved by the Ethics Committee of Huashan Hospital affiliated to Fudan University, Shanghai, China. All patients were given detailed oral and written information on the study and its aims and risks, and gave their written consent before entering the study.
MEASUREMENTS
Glycaemia was measured at 0 and 120 min, according to World Health Organization guidelines: 6 DM was defined as FPG ≥ 7.0 mmol/l and/or oral glucose tolerance test 2h post-load plasma glucose (OGTT 2hPG) ≥ 11.1 mmol/l; IGT was identified as FPG < 7.0 mmol/l and OGTT 2hPG ≥ 7.8 mmol/l to < 11.1 mmol/l; IFG was defined as FPG ≥ 6.1 mmol/l to < 7.0 mmol/l and OGTT 2hPG < 7.8 mmol/l; (NGT) was identified as FPG < 6.1 mmol/l and OGTT 2hPG < 7.8 mmol/l.
Using the VP-1000 Automatic Arteriosclerosis Measurement System (model BP203RPE-II; Colin Co. Ltd., Komaki, Japan), the brachial-ankle pulse wave velocity (baPWV) was simultaneously measured by bilateral brachial and tibial arterial pressure waveforms, lead I electrocardiogram and phonocardiogram. 7, 8 In this study, baPWV was calculated as the mean of the left and right baPWV values. The measurement was conducted after the patient had rested for ≥ 5 min in a supine position in an airconditioned room (24 -26°C). Participants were advised to refrain from smoking, drinking alcohol or caffeinated beverages and from taking heavy exercise for at least 2 h prior to measurements being taken.
STATISTICAL ANALYSIS
Variables are presented as mean ± SD. Statistical evaluation of the data was carried out using the SPSS ® statistical package, version 10.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . The significance of mean differences was tested by analysis of variance. Differences between categorical variables were tested using the χ 2 -test. A P-W Gong, Z Yang, W Ye et al. Dysglycaemia and CV disease in metabolic syndrome value < 0.05 was considered to be statistically significant.
Results
In total, 175 males and 415 females with MetS participated in the study, with an overall mean ± SD age of 59.82 ± 9.69 years. The anthropometric, laboratory and clinical characteristics of the study population are presented in Table 1 . Compared with male patients, female patients with MetS had a significantly lower waist circumference, DBP, triglyceride level, FPG and OGTT 2hPG, and significantly higher HDL-C levels (all differences P < 0.05).
The clinical characteristics of the MetS patients, categorized according to their glucose regulation status are shown in Table 3 . For almost all of the components of MetS, such as waist circumference, triglyceride level, SBP and DBP, patients with FPG ≥ 7.0 mmol/l had the least favourable values. Patients with FPG < 5.6 mmol/l had the lowest HDL-C levels compared with the other patients (P < 0.05) and the highest triglyceride levels (P < 0.05 versus all patients except those with FPG ≥ 7.0 mmol/l). There were significant differences in baPWV between patients with FPG ≥ 7.0 mmol/l and the other three subgroups (P < 0.05).
Discussion
Previous prospective studies have shown that MetS, regardless of how it is defined, is a significant predictor of diabetes in many different populations, including Native 9, 10 As shown in the present study, dysglycaemia was so common in this population of Chinese patients with MetS that only 19.5% of them had normal FPG and normal OGTT 2hPG levels simultaneously. According to IDF criteria, 5 the cut-off level for normal FPG is 5.6 mmol/l. Among patients in the present study with FPG ≥ 5.6 mmol/l to < 7.0 mmol/l, the rates of CGI and DM were 42.9% and 18.4%, respectively. Even in patients whose FPG level was < 5.6 mmol/l, 23.0% were diagnosed with IGT and 7.3% with DM using the OGTT 2hPG. As MetS is a common pathophysiological condition with implications for the development of many chronic diseases and as hyperglycaemia is the main contributor to MetS, more attention should be given to this field. 11 -13 Peripheral arterial disease (PAD) in the lower extremities signals widespread arterial disease and a high risk of stroke, myocardial infarction and death. Because many patients with diabetes also have PAD, the American Diabetes Association now recommends testing for PAD in any patient with diabetes aged > 50 years. 14 The baPWV has been reported as a predictor of atherosclerosis. 15, 16 Patients with DM and CGI in the present study had the highest baPWV values. The baPWV for patients with DM was significantly higher than all the other subgroups, whereas the baPWV for the CGI subgroup was only significantly higher compared with the IFG group. Patients with CGI have the greatest risk for future type 2 diabetes and it is worth noting that, in the present study, patients with MetS combined with CGI were already at risk of cardiovascular disease.
Least favourable glucose control in the patients with MetS was associated with a greater risk for cardiovascular disease. This relationship may be due to either a greater difficulty in achieving glucose control in patients with MetS and/or an aggravating role of poor glucose control on the components of MetS. 17 For instance, it is well known that glucose control is inversely related to triglyceride levels. 18 In this observational analysis, age, waist circumference, lipid levels and blood pressure were significantly different in patients diagnosed with DM compared with those individuals with NGT.
In conclusion, dysglycaemia was found to be common in Chinese patients with MetS and an increased prevalence of cardiovascular disease in patients with MetS was related to their glucose regulation status.
